The dose-dependent effects of MK-801, a glu tamate receptor antagonist, on changes in CBF, CBF Pac02 responsiveness (133Xe clearance), EEG, and blood-brain barrier (methylene blue) were examined after a IS-min period of reversible complete global ischemia induced in halothane-anesthetized cats by occlusion of the vertebral and carotid arteries. Pretreatment with doses of MK-80l of ;;.0.5 mg/kg had no effect on resting CBF measures and produced a dose-dependent slowing of the dominant EEG frequency. In animals receiving this agent, there was an almost immediate return of baseline EEG patterns upon reinstitution of flow, no hypoperfu sion after 2 h of reflow, preservation of CBF and CBF P ac02 responsiveness, and maintenance of blood-brain barrier integrity. In contrast, parallel control animals and animals treated with MK-80l at a dose of 0.1 mg/kg ex hibited poor recovery based on the above parameters.
Cerebral anoxia as a concomitant of occlusive ce rebrovascular disease or cardiorespiratory failure is a frequent cause of human neurological injury. De spite the complexity of the problems induced by progressive metabolic deficits, it has become clear that the pathophysiology of the hypoxic brain re flects an evolving series of events that include changes in intracellular calcium homeostasis, ele vated free fatty acid concentrations, accumulation of eicosanoids, and increased extracellular lactic acid. All of these variables appear to be associated MK-80l also diminished in a dose-dependent manner the CSF levels of 6-keto-prostaglandin (PG) F I", (stable me tabolite of PGI2) and thromboxane (Tx) B2 (stable metab olite of TxA2) , which were otherwise elevated in vehicle treated animals 2 h after reflow. Of particular interest, the CSF TxB2/6-keto-PGF I", ratio in vehicle-treated animals was near 2. In animals pretreated with MK-80l, at doses of ;;'0.5 mg/kg, this ratio was nearly 1. These observa tions are consistent with a possible triggering role of glu tamate release in initiating at least part of the acute se quelae of ischemia. Such release in an electrically silent cell would increase Ca 2 + influx and activate free fatty acid metabolism, leading to probable changes in vascular function and changes in blood-brain barrier permeabil ity. Key Words: Cerebral ischemia-Ischemia and glutamate-N-methyl-o-aspartate antagonists-MK-80l-Prostacyclin-Thromboxane.
with developing neuronal dysfunction observed fol lowing the onset of ischemia (Siesjo, 1981 (Siesjo, , 1984 Siesjo and Wieloch, 1983) . More recently, an addi tional variable has been the hypothesized role of excitatory amino acid neurotransmitters such as glutamate and aspartate in neuronal injury following ischemia. Four lines of evidence suggest a probable role for this system in the neuronal response to isch emia.
1. Exogenously administered glutamate results in neuronal loss after focal administration in vivo (Mc Bean and Roberts, 1984; Rothman, 1984) and in in vitro preparations (Dingledine, 1983; Choi, 1985;  Clark and Rothman, 1987) , in those regions of the central nervous system with a high density of glu tamatergic synapses (Fagg and Foster, 1983;  Roth man and Olney, 1986) . This effect appears receptor mediated as it is blocked by agents known to act as competitive and noncompetitive antagonists (see Meldrum, 1985b) at one or more of the three prob able glutamate receptors [N-methyl-D-aspartate (NMDA), quisqualate, kainate] (Monaghan et aI., 1983; Greenamyre et aI., 1985) .
2. Extracellular levels of glutamate and aspartate in brain rise after the onset of ischemia (Benveniste et aI., 1984; Drejer et aI., 1985; Hagberg et aI., 1985) . As glutamate is actively taken up by neuronal and glial elements, the failure of energy-dependent uptake during ischemic events would yield in creases in extracellular amino acids (Benveniste et aI., 1984; Rothman and Olney, 1986) . Glutamate releasing neurons may be rendered excitable by the increase in extracellular potassium that is known to occur during ischemia (Astrup et aI., 1977; Siesj6, 1981) .
3. Regions of the central nervous system where glutamate receptors are in high density coincide with those areas considered to be most vulnerable to ischemia, e.g., layer III of the cortex, the stria tum, and notably the CAl region of the hippocam pus (Meldrum et aI., 1982; Simon et aI., 1984a; Rothman and Olney, 1986) . In the case of the hip pocampus, lesion of the perforant pathway, the principal excitatory input, likely employing an ex citatory amino acid (Collingridge et aI., 1983) , will diminish the cell death otherwise evoked by global ischemia in the rat (Pulsinelli, 1985) .
4. The crucial observation linking the excitotoxic effects of glutamate and ischemia is the effect of glutamate receptor antagonism. A number of recent studies have indeed suggested that administration in vitro [cell culture: Choi (1985) ; hippocampal slices: Clark and Rothman (1987) ] and in vivo of agents behaving as competitive and noncompetitive antag onists at glutamate receptors will diminish the inci dence of cellular degeneration and the neurological sequelae induced by ischemia or hypoxia (Simon et aI., 1984b; Boast et aI., 1987; Foster et aI., 1987; Gill et aI., 1987; Kochlar et aI., 1988; Ozyurt et aI., 1988; Swan et aI., 1988) .
MK-801, (+ )-5-methyl-l0, II-dihydro-5H-di benzo[a, d]cyclohepten-5, 10-imine, is a water soluble, selective, noncompetitive, open channel blocker at the NMDA receptor site. It has anticon vulsant, central sympathomimetic, and anxiolytic ef fects (Clineschmidt et aI., 1982; Wong et aI., 1986) . It crosses the blood-brain barrier and has a half-life of -1 h (Hucker et aI., 1982) . Our aim in the present study was to examine the dose-dependent effects of MK-801 on EEG, cerebrovascular responsiveness to P aco2, blood-brain barrier, and levels of throm boxane (Tx) B2 and 6-keto-prostaglandin (PG) F lOt in CSF after 15 min of total global ischemia in the J Cereb Blood Flow Metab. Vol. 10, No. 1, 1990 halothane-anesthetized cat, a model with which this laboratory has had prior experience (Stevens et aI., 1986) .
METHODS

General preparation
Cats (n = 21) of either sex weighing 2.5-4.5 kg were fasted 12-18 h prior to experimentation, with free access to water. After induction of anesthesia with 4% halothane and O2, a tracheal tube was inserted and the surgical preparation carried out under 1.5-2.0% halothane. Halo thane (1 %) delivered by a calibrated Fluotec system in an 02/air/C02 mixture (1.0:5.0:0.02) was used for mainte nance during the remainder of the experiment. Pancuro nium bromide (0.15 mg i.v.) was used to achieve initial muscle paralysis, followed by smaller periodic doses as needed to maintain ventilatory control after the animal was placed on a Harvard respirator. The right femoral artery and vein were cannulated to monitor blood pres sure, obtain sequential samples for blood gases, and ad minister drugs. The left femoral artery was additionally catheterized to permit the withdrawal and injection of blood while monitoring the MABP. Arterial blood gases and pH were measured with a Radiometer blood gas an alyzer. Rectal temperatures were monitored and the ani mals were maintained at normothermia by use of an un derbody heating blanket and a proportional feedback tem perature controller at a rectal temperature of 37.5°C with a range of 1°C.
To permit the immediate induction of a rapidly revers ible complete cerebral ischemia, the thyrocervical, inter nal thoracic, and vertebral arteries were identified via a transaxillary approach with use of an Olympus operating microscope and occluded bilaterally with bipolar cautery. This eliminated all blood flow to the head except that from the carotid arteries and the small amount supplied by the spinal arterial cascade (Hossmann et aI., 1976) . The carotid arteries were then exposed with care taken to avoid distortion of the adjacent vagal nerve; silk ligatures were loosely placed around each artery.
Experimental sequence
The typical experimental sequence consisted of surgi cal preparation (=75 min) and the injection of drug (or saline), assessment of preischemia CBF-P ac02 response function, initiation of ischemia for 15 min, reflow for 2 h, assessment of postischemia CBF-Pac02 response func tion, and injection of 1 ml of methylene blue via the lin gual artery; after 5 min of circulation the animals were killed. Also prior to death, removal of CSF from the cis terna magna was performed for later prostanoid measure ments.
Five groups of cats were used to evaluate the changes in CBF, CBF-Pac02 responsiveness, EEG recovery, and blood-brain barrier after a 15-min period of reversible complete global ischemia in control and MK-801pretreated animals. Following preparation, a cat was ran domly assigned to receive vehicle (n = 4), MK-801 0.1 mg/kg (n = 4), MK-801 0.5 mg/kg (n = 5), MK-801 1.0 mg/kg (n = 5), or MK-801 2.0 mg/kg (n = 3). The treat ment was administered intravenously 15 min prior to the preischemic Pac02-CBF response sequence. The experi ment began once maximal EEG change occurred, which was typically 5-10 min after administration of MK-801.
Reversible complete cerebral ischemia was achieved by lowering the MABP of the animals to =80 mm Hg by the withdrawal of arterial blood via a heparinized syringe and occluding the carotid arteries with aneurysm clips placed on each. The jaws of these clips had sufficient pressure to eliminate blood flow through the carotid ar tery without visibly damaging it when removed. Exami nation of the EEG revealed no change during the brief interval of hypotension prior to occlusion, but a complete loss of activity within 10--15 s of the placement of the aneurysm clips. The completeness of the ischemia was monitored by injecting 133Xe via the right lingual artery catheter just prior to the clipping of the carotid arteries. Ischemia was considered complete only when 133Xe ac tivity levels did not decrease by > 10% during the IS-min occlusion interval (Hossmann et aI. , 1976) . In general the washout curve generated during the IS min had an effec tive slope of zero with little detectable washout until ca rotid flow was reestablished. Reflow was established by reinfusion of blood through the right femoral vein cathe ter �30 s before the end of the IS-min ischemic period and removal of the aneurysm clips from the carotid arter ies.
To assess the functional response of the cerebral vas culature, the CBF response to changes in Pco2 was de termined by examining 133Xe washout under a sequence of normocarbia, hypocarbia and hypercarbia, and normo carbia with nominal P aco2 values of 40, 20 and 60, and 40 mm Hg, respectively. In each case Paco2 was adjusted by changing the concentration of CO2 in the inspired gas and ventilatory rate for 10--15 min before 133Xe injection. Arterial blood gases were determined immediately before the CBF measurement. Throughout the experiment, P a02 was maintained above 90--100 mm Hg.
CBF measurement
To measure CBF, 133Xe was administered through a polyethylene (PE-50) catheter placed into the right lingual artery such that the tip of the catheter was at the bifur cation of the lingual and carotid arteries. After the head of the cat was secured in a stereotaxic head holder, the skin, subcutaneous tissue, and temporalis muscle were re flected to expose the right temporoparietal portion of the skull. An external scintillation probe was positioned over this area. The calibration, collimation, and isoresponse curve of this detection used in this laboratory have been described previously (Cillufo et aI., 1981) . CBF was mea sured by monitoring the clearance of a 0. 1-to 0.2-ml bolus of normal saline containing 200 f.LCi of 133Xe injected into the right lingual artery. CBF was then calculated via the 133Xe washout curve using the I-min initial slope index method, a modification of the 2-min flow index method of Hutten and Brock (1969) .
EEG
To monitor EEG activity, two parasagittal I-mm drill holes were made bilaterally. Four gold-plated pins were placed in these holes by which two-channel EEG moni toring was carried out with a Grass model 6 electroen cephalograph (see inset in Fig. 5 ).
PG measurement
CSF was removed from the cisterna magna of each cat at the end of each experiment immediately prior to death for measurement of prostanoid levels. 6-keto-PGF 1 <> (the stable metabolite of PGI2, prostacyclin) and TxB2 were extracted, concentrated, and measured via radioimmuno-assay. This assay was carried out using commercially available tests from Biotech, Inc. (Granstrom and Kin dahl, 1976 ). The percentage cross-reactivity of the assays was 0.0330 for TxB2 and 0.0120 for 6-keto-PGFI<>. The absolute sensitivity of the assays was 0. 5 pg/O.l ml for both TxB2 and 6-keto-PGFI<>.
Blood-brain barrier evaluation
Prior to death in 17 of the animals, 0. 3 mllkg of meth ylene blue (1%) was injected slowly (over 2 min) via the lingual artery and allowed to circulate for 5 min. The brains were harvested and a section of right forebrain was placed in a freezer at -50°C for later grading of methyl ene blue parenchymal extravasation as a measure of blood-brain barrier integrity. A grading system of 0--3 was applied to each block by five independent examiners unaware of the treatment protocol: 0 = no visible stain; I = mild staining; 2 = moderate staining; and 3 = severe staining. The sum of all five grades was tabulated for each specimen and its percentage of 15, the maximum staining grade that could be achieved from five graders, was cal culated and plotted.
Statistics
Data are presented as means ± SE or as percentage change from baseline. The best-fit line for each of the CO2 responses measured for each animal was determined us ing a least-squares linear regression. Preischemic differ ences in MABP, number of delta waves seen in EEG per lO-s epochs, and postischemia values were determined by analysis of variance and the Newman-Keuls test. Differ ences that reached critical values corresponding to p < 0.05 were considered significant. Comparisons between scored data (such as brain methylene blue staining and pre-and postischemic EEG comparisons) were carried out using a nonparametric statistic, the Wilcoxon rank sum test.
RESULTS
Control studies
In previous work with this identical halothane anesthetized cat model (Stevens et aI., 1986) , we showed that normocarbic blood pressure and rest ing 1 33 Xe clearance did not change over an identical 2-h interval. Examination of the slope of the P aco2 response function, in the beginning and after 2 h, also revealed no change. These data indicate the stability of the preparation over time.
MK-801: MABP and MABP-Paco2 responsiveness
Preischemia. MK-801 significantly increased resting, normocarbic MABP from 126 to 146-150 mm Hg. This increase was seen at the lowest dose of MK-80l (0.1 mg/kg), with no further statis tically significant increases observed at higher doses. Increasing Paco2 resulted in a linear increase in MABP (see Fig. 1, top) . The group mean slope of the MABP-P aco2 response prior to drug treatment and ischemia was 0. 51 ± 0.04 mm Hg/torr. As shown in Fig. 1 , a dose-dependent increase in the slope of the MABP-Paco2 response was observed, with a 2.5-fold increase in slope being observed at the highest dose. Postischemia. As in previous studies, following the initiation of reperfusion and the gradual reinfu sion of blood, all animals displayed a return of MABP to approximately preischemic levels. Com parison of MABP at this time showed no statistical differences between groups as a function of dose (p > 0. 20, data not shown). At 2 h following reflow, though there was a trend for drug-treated animals to show an elevated MABP, this did not statistically differ as a function of drug dose (p > 0. 20, data not shown). At 2 h following a IS-min period of com plete global ischemia, the response of MABP to change in P ac02 was severely blunted (see Fig. 2 ). MK-801 resulted in a dose-dependent preservation of the MABP-PaC02 response (see Fig. 2 ). Thus, at the two highest doses, postischemic MABP-Paco2 response slopes averaged �84 and 85%, respec tively, of their preischemic slopes, values signifi cantly greater than those observed in vehicle treated control animals (p < 0. 05).
MK-801: CBF and CBF-P ac02 responsiveness
Preischemia. With \33 Xe clearance, CBF under control conditions was 76. 3 ± 2. 1 ml/l00 g/min (n = 21), and there was no difference between the sev- eral treatment groups (see Figs. 1 and 3 ). Increasing CO2 resulted in the expected increase in cerebral flow (see Fig. 4 ). MK-801 at doses from 0. 1 to 2. 0 mg/kg had no effect on either normocarbic CBF or the slope of CBF-P aco2 responsiveness ( Fig. 1) .
Though not tested directly, the lack of effect of MK-801 on normocarbic CBF or on the slope of the P aco2-CBF response curve in the face of increased normocarbic MABP and an augmented P aco2-MABP response curve (see above) suggests that MK-801 has no effect on pressure autoregulation in this range of MABP. Postischemia. In Fig. 3 normocarbic CBF is plot ted over time before, during, and after a IS-min period of global ischemia. All animals had similar normocarbic CBF (between 73 and 82 ml/IOO g/min) prior to induction of ischemia. Within seconds of the occlusion of the carotid arteries, the slope of the \33 Xe clearance curve became essentially zero [see typical records in Stevens et a1. (1986) ]. After 15 min of complete global ischemia, all cats experi enced a 15-to 20-min period of hyperemia of ap proximately the same degree (120-150 ml/100 g/min) ( Fig. 3 ). In the control and MK-801 (0. 1 mg/ kg)-pretreated groups, the CBF declined steadily following the initial hyperemia, and by 120 min after reflow, all animals displayed a normocarbic flow below 25 ml/IOO g/min. In contrast, with one excep tion each in the 0. 5-and I. O-mg/kg groups, no ani mal pretreated with 0. 5, l. 0, or 2. 0 mg/kg displayed evidence of hypoperfusion during the 2-h period of postreflow, and all three dosages were equally ef fective in this (see Fig. 3 ). As shown in Fig. 4 , a 15-min period of global ischemia in control and O. I-mg/kg-pretreated cats severely blunts the CBF response to changes in Paco2. Those animals pretreated with 0. 5, l. 0, or 2. 0 mg/kg of MK-801 showed remarkable preserva tion of their CBF-Paco2 responsiveness after isch emia, with the slopes being not statistically different in magnitude as compared with their preis chemic responses (p > 0. 20). One animal in each of the 0. 5and l. O-mg/kg groups did experience severe post ischemic blunting of its CBF-P aco2 response. These were the same animals that experienced the pro found delayed hypoperfusion.
EEG
Preischemia. In halothane-anesthetized cats, MK-801 produced prominent slowing and a corre-lated increase in amplitude of the EEG (Fig. 5) , which appeared to be dose dependent (see Figs. I and 5) over the range of 0. 1-2. 0 mg/kg. Thus, even at the lowest dose (0. 1 mg/kg), there was a signifi cant increase in delta activity from control, with maximum slowing being observed at doses of �0. 5 mg/kg (see Fig. 1 ). These effects were reliably seen within 1-2 min after intravenous administration of the drug and were maximal in 5-10 min.
Postischemia. All groups showed rapid flattening of the EEG pattern with occlusion (Fig. 6, top) . Upon reflow, both the control group and animals pretreated with 0. 1 mg/kg of drug failed to show any recovery of EEG activity, even after 120 min of reflow. Those animals pretreated with 0. 5, l. 0, and 2.0 mg/kg (except for the one animal in each of the 0.5-and I. O-mg/kg-treated groups) showed almost immediate recovery of preischemic EEG patterns upon reestablishment of cerebral circulation (Fig. 6 , bottom). Figure 6 (top) shows the typical EEG pat terns before, during, immediately after, and after 120 min of reflow in a control and a 0. 5-mg/ kg-pretreated cat.
Arterial pH Figure 7 shows that during the sampling period 5 min following reflow control cats were significantly more acidotic than animals pretreated with any dos age protocol of MK-801 (7.15 vs. 7.26). No other sampling periods showed any statistically signifi cant difference between groups of animals. This ini tial acidosis was resolved by the 15-min sampling period. This acute postreflow systemic acidosis may reflect the washout of cerebral lactic acid and free fatty acids that accumulated during the 15-min ischemic period.
Blood-brain barrier Figure 8 presents the results from 17 animals in which the relative levels of methylene blue in brain were assessed. As indicated, the control and Typical EEG patterns seen in a control and a MK-801 (0.5 mg/kg)-pretreated cat before, during, immedi ately after, and 2 h after a 15-min period of ischemia. CBF measurements (m1/100 g/min) during the time period of EEG recordings are also indicated. Bottom: Plot of the percentage of animals whose EEG records after 2 h of reflow were sim ilar to or better than their baseline EEG records. 'Statistically significant difference from control based on Wilcoxon rank sum test (p < 0.05).
O. l-mg/kg groups showed the highest levels of methylene blue. In contrast, four of five cats in the 0. 5-and 1. 0-mg / kg groups and all three animals in the 2. 0-mg/kg group displayed significantly less methylene blue uptake. Also indicated are those cats in which poor EEG recovery was observed. Importantly, there was an absolute correlation between the severity of the methylene blue uptake and the failure of EEG re covery. Thus, one animal each in the 0. 5-and 1. 0-mg / kg groups showed severe staining. These an imals both had profound delayed hypoperfusion, Open circles represent animals that had baseline or better EEG activity after 2 h of reflow. Animals that were pretreated with MK-801 at dosages of 0.5, 1.0, and 2.0 mg/kg had statis tically less methylene blue staining (p < 0.05) based on Wilcoxon rank sum test.
blunted postischemic CBF-Paco2 response curves, and poor EEG recovery. This difference between the control and O. l-mg / kg groups and the 0. 5-, 1. 0-, and 2. 0-mg/kg groups was statistically significant (p < 0. 05) via Wilcoxon rank order analysis.
PG Figure 9 (bottom) presents the mean and SE of TxB2 and prostacyclin (6-keto-PGF 10l' the stable metabolite) concentrations in the cisternal CSF. In the absence of drug, prominent levels of TxB2 and 6-keto-PGF 10l were observed in cisternal CSF 2 h after reflow. Calculation of the TxB2 / 6-keto-PGFI0l ratios suggests a relative accumulation of TxB2 after ischemia; i. e. , the ratio is 1. 82 (p < 0. 05) (Fig. 9,  top) . MK-801 results in a significant dose dependent reduction in the elaboration of pros tanoids into the CSF, in particular, a statistically significant reduction in TxB2 (p < 0. 05) ( Fig. 9 , bot tom).
DISCUSSION
Sequelae of ischemia
Following bilateral occlusion of the carotids and mild hypotension in halothane-anesthetized cats with ligated vertebral arteries, there was a reliable blockade of the cerebral clearance of 1 33 Xe and a complete loss of the cortical EEG. As in previous studies with this model, after reflow a syndrome of events was observed that included hyperemia fol lowed by a progressive hypoperfusion in the face of maintained MABP; a severe loss of the cerebrovas cular and cardiovascular response to CO2; contin ued abolition of EEG activity; an elevation in the CSF TxB2 / 6-keto-PGFI0l ratio; and an increase in cerebral plasma extravasation. These observations clearly present a complex profile of events that sug gest a deterioration of central nervous system func tionality. Animals treated, prior to ischemia, with MK-801 in doses of :;:;':0. 1 mg / kg displayed a prominent dose dependent shift to high-voltage slow wave EEG and no change in cerebrovascular reactivity. While pre treatment with MK-801 had no effect upon the MABP or the hyperemia observed immediately fol lowing reflow, doses of :;:;,:0. 5 mg/kg led to an almost immediate reappearance of EEG activity after re flow, a marked attenuation of the delayed cerebral hypoperfusion, maintenance of the CBF-and MABP-P C02 response function, reduction in the magnitude of plasma extravasation, and normaliza tion of the CSF TxB2/6-keto-PGF1a ratio. These ob servations raise several issues.
Membrane mechanism of action of MK-801
At the membrane level, glutamate receptor occu-. . N + d C 2 + pancy evokes an mcrease m a an a permeability (Choi, 1985; Rothman and Olney, 1986) , leading to neuronal depolarization and an associ-ated influx of Cl-and water, each driven by corre sponding electrochemical and osmotic forces (Ol ney et aI., 1971; Fagg et aI., 1982; Rothman, 1985) . These events acutely result in a significant increase in intracellular volume, leading to additional depo larization as intracellular K + concentration falls (Astrup et aI. , 1977; Siesjo, 1981 Siesjo, , 1984 . These events would thus correspond with an acute inacti vation of neuronal function and cell death (if cell volume became excessive) and possibly set in mo tion irreversible processes that lead to progressive deterioration over the ensuing hours to days, e. g., failure of ionic transport systems, accumulation of intracellular Ca 2 + (Donaldson et aI. , 1983; Dienel, 1984; Simon et aI. , 1984a; Choi, 1985) , and forma tion of reactive intermediaries (Siesj6 and Wieloch, 1983; Kontos, 1985) . Such a formulation has further appeal as it appears to provide some common mechanism for the sequelae observed following sta tus epileptic us , hypoglycemia, and ischemia (Far ber et aI., 1981; Siesj6, 1981 Siesj6, , 1984 Raichle, 1983; Greenamyre, 1986) , as well as toxicity following the focal activation of amino acid receptors (Olney, 1978; Meldrum, 1985a,b; Rothman, 1985; Wieloch, 1985a,b) .
The above scenario, in its simplest form, thus requires that after the onset of ischemia, there will be (a) an early release of an excitatory amino acid, (b) paroxysmal depolarization of the cell, and (c) conditional changes in neuronal function such that acutely the sequelae are reversible but, at some point in the absence of excitatory amino acid recep tor antagonism, become irreversible.
While excitatory amino acid release after the on set of ischemia has indeed been demonstrated (see introductory section), single-unit activity in cortex and brainstem (Heiss et al., 1976; Branston et aI. , 1979) , cortical evoked potentials (Branston et aI. , 1979; Chiappa, 1983; Stevens et aI., 1986) , and even electrocorticograms (Sharbrough, 1973; Siesj6, 1981; Stevens et aI. , 1986) show evidence only of a progressive and rapidly deepening electrical silence with no bursting activity. It is possible that the pre ponderance of cells may become electrically silent during ischemia, while others not examined during the onset of ischemia may show progressive in creases in activity. Whether those that show an in crease are those that eventually succumb, and whether it is this population of cells that are pre served by excitatory amino acid antagonism, is not known.
Alternatively, it appears likely that the electrical silence results from the acute loss of energy sub strate (Lipton and Whittingham, 1982) , the progres sive depolarization of the neuronal membrane in the presence of a rise in extracellular K + (Astrup et aI. , 1977) , and the loss of conducted potentials as volt age-sensitive ion channels become progressively in activated. Under these conditions, those cells sen sitive to glutamate might thus not be driven to bursting. In spite of this electrical silence, it is prob able that glutamate continues to act at the mem brane via a receptor-mediated mechanism to have deleterious effects on cell function. Thus, Connor and colleagues (1988) observed in tetrodotoxin treated hippocampal neurons, where glutamate evoked bursting was prevented, that the repetitive local application of glutamate would evoke a sus tained influx of Ca 2 + into the dendrites. These ef fects were blocked by 2-amino-5-phosphonovaleric acid or Mg 2 + , agents that block the NMDA recep tor. Of particular significance, a prominent den drosomatic gradient is created that suggests the probable increased utilization of ATP stores to drive a Ca 2 + antiporter. Thus, following the onset of ischemia, a cerebral electrical silence occurs that is glutamate independent (i. e. , unaffected by MK-801). The release of glutamate because of K + induced membrane depolarization and the subse quent action of glutamate at an NMDA site will thus result in significant increases in Ca 2 + flux via an NMDA-like receptor-linked channel (Berdichesky et aI. , 1983; Dingledine, 1983; Choi, 1985) . This markedly increases intracellular Ca 2 + with the at tendant activation of Ca 2 + -dependent enzymes and an increase in the activity of energy-dependent transport systems resulting in increased metabolic activity. It appears an inescapable conclusion that this mobilization occurs in spite of the deep EEG silence. Consistent with this hypothesis is the fact that MK-801 treatment prevents the acute and tran sient arterial acidosis that otherwise occurs subse quent to reflow (Sundt and Waltz, 1971; Cillufo et aI. , 198 1) and reflects the accumulation of acid equivalents, presumably lactate, during the anoxic interval. This suggests that MK-801 was possibly effective in suppressing changes in excess cellular metabolic activity that normally occurs during isch emia. While a blockade of cerebral activity as pro duced by hypothermia or barbiturates might simi larly suppress lactate production during ischemia (Branston et aI. , 1979; Cillufo et aI. , 1981) , this ef fect with MK-801 was not at the expense of cerebral electrical silence in the preischemic phase. This fur ther supports the possibility noted above that dur ing ischemia there is a suppression of cellular neu ronal activity; but even in the absence of electrical indexes of cell bursting, the activation of glutamate receptors may drive various phases of the metabolic activity of the electrically silent cell.
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The mechanism of the increased prostanoid se cretion during ischemia has been discussed in detail elsewhere (Moskowitz and Coughlin, 1981; Siesjo and Wieloch, 1983; Stevens and Yaksh, 1988) , but probably reflects the presence of increased intra cellular Ca 2 + secondary to the opening of voltage sensitive Ca 2 + channels during depolarization or by the activation of receptor-linked Ca 2 + channels, as has been demonstrated to occur with glutamate (Berdichevsky et aI. , 1983; Choi, 1985; Connor et aI. , 1988) . Of particular interest is the observation noted previously that prolonged elevations in intra cellular Ca 2 + may be generated by the repeated presence of glutamate (Connor et aI. , 1988) . It has also been shown that during electrical or chemically evoked seizures, PG levels in tissue and in the ex travascular-extracellular space increase remarkably (Bazan, 1970; Poddubiuk, 1976; Divinitez-Romero et aI. , 1984; Navarro et aI. , 1989) . Under these cir cumstances, it is thus not surprising that, to the extent that glutamate is released and increases Ca 2 + influx, glutamate receptor antagonism would lead to a reduction in ischemia-evoked changes in prostanoid synthesis and release.
Effects of MK-801 on ischemia-induced changes in physiological fu nction EEG. The prominent observation in cerebral ischemia is the rapid loss of EEG following occlu sion of flow. Failure to recover EEG acutely fol lowing removal of the occlusion may reflect a fail ure of regional reperfusion (Trojaborg and Boysen, 1973; Siesjo, 1984) . Indeed, marked heterogeneity in reflow has been described with deep brain re gions showing prominent regions of no flow (Ames et aI. , 1968; Rehncrona et aI. , 1979) . Because of "look-through, " the use of 1 33 Xe permits us to say only that significant reperfusion occurred in both drug-and non-drug-treated groups, but does not es tablish that the flow was homogeneous. The rapid recovery of cortical EEG activity in the immediate postischemia period in MK-801-treated animals was surprising. This is in contrast to the delayed recovery of the EEG observed during re flow in this feline model after pretreatment with cy clooxygenase inhibition. In the latter case, it ap peared reasonable to speculate that the progressive recovery was dependent upon the temporal reversal of events produced by ischemia permitted by the absence of a delayed hypoperfusion phase (see be low; Stevens and Yaksh, 1988) . Jointly, we believe the effects of these two distinct classes of drugs suggest that the increased activity at the NMDA receptor during ischemia may lead to events that are manifested by electrical silence even in the pres-ence of significant reperfusion. Thus, even though the tissue in this model has rapidly regained some degree of metabolic competency, the NMDA mediated events prevent the appearance of sponta neous neuronal activity. This would indicate that maximum influence of NMDA antagonism would be seen if the receptor were antagonized during the ischemic state. It is interesting to speculate that to the degree that events (e. g. , the products of free fatty acid metabolism) initiated by glutamate re lease during the ischemic period influence blood flow or alter the neuronal economy (e. g. , oxidation of cytoplasmic protein), the efficacy of postisch emic glutamate receptor antagonism would be di minished. In such cases, pretreatment with cyclo oxygenase inhibitors in conjunction with postisch emic NMDA antagonism might provide some insight into the temporal order of events.
CBF. MK-801 had no effect on resting CBF or the CBF-Paco2 response function in the nonischemic animal at its highest dose. Yet, it appeared to pre serve in a dose-dependent fashion the CBF other wise attenuated in the later reflow phase. The pro gressive decline of normocarbic CBF during reflow in control and inadequately treated animals may oc cur secondary to increasing intracranial pressure (Siesjo, 1984) or a progressive vasoconstriction re sulting from pharmacologic mechanisms (Siesjo and Nilsson, 1982; Kontos, 1985) . Thus, ischemia may alter the function of vascular endothelium, leading to a loss of the ability to release relaxing factor (Moncada, 1983) . Alternatively, there is evidence that the progressive hypoperfusion is sensitive to PG synthesis inhibition (Okabe et aI. , 1983; Stevens et aI. , 1986) .
In previous work with this model, we have shown that following ischemia, there is a progressive in crease in the levels of several cyclooxygenase prod ucts including TxB2 and 6-keto-PGF la (Stevens and Yaksh, 1988) . These levels reach maximum during the hour following reflow. Of interest, however, is that the TxB2/6-keto-PGFla ratio rises from �1 prior to ischemia to a maximum of � 30 at �60 min of reflow, a time that correlates quite well with the onset of delayed hypoperfusion. It is significant not only that MK-801 administration, in a dose dependent fashion, resulted in a significantly dimin ished elaboration of TxB2 and 6-keto-PGF la assayed from cisternal CSF collected just prior to death 2 h after reflow, but also that the TxB21 6-keto-PGF la ratio dropped from 2 in control ani mals to 1 in MK-801-pretreated animals. Such a ra tio change suggests that treated animals displayed a "prodilation" balance in the production of Tx (a powerful vasoconstrictor and platelet aggregator) and of prostacyclin (a powerful vasodilator and dis aggregator of platelets) (Moncada et aI. , 1980) . This balance in production of TxA2 and PGI2 would ap pear to be an important variable in the regulation of CBF (Moskowitz and Coughlin, 198 1; Pickard, 1981; Stevens and Yaksh, 1988) and may be one way in which MK-801 exerts its beneficial effects. Topple et aI. (1987) observed in hippocampal slices that hypoxia led to a prominent vasoconstriction. This vasoconstriction appears linked to the local release of vasoactive materials. This ex vivo obser vation and the developing body of literature cited above are thus consistent with the hypothesis that hypoxia leads to an initial electrical silence, a re lease of glutamate, and activation of second mes senger systems that result in the local secretion of a preponderance of vasoconstrictive agents such as TxA2·
Preservation of the CBF-P aco2 and MABP-P aco2 response functions otherwise lost during ischemia may reflect an ischemia-evoked dysfunction in a central nervous system structure. Thus, it has been shown that electrolytic lesions of the brainstem, no tably in the region of the locus ceruleus, can dimin ish the slope of the CBF MABP-P aco2 response curve (Reddy et aI. , 1986) in the pentobarbital anesthetized cat. Preservation by MK-801 of the CO2 response function of CBF and MABP, as with the EEG, may thus reflect the protection of neurons that normally would succumb from prolonged acti vation of NMDA channels by excitatory amino ac ids during ischemia. However, because (a) the blood pressure observed during the acute reperfu sion stage was similar in all groups and (b) the mag nitude of the estimated blood flow between groups during the initial hyperemic stage did not signifi cantly differ, we do not believe that the acute EEG recovery in MK-801-treated animals reflected a di rect effect on reperfusion.
The considerations outlined above suggest that during the onset of ischemia, there is an initial in activation of the cell mediated by a progressive de polarization, which is probably independent of a glutamate receptor, and a second series of unde fined events that result during the IS-min period of ischemia in a loss of cell function related to the activation of an NMDA receptor. The rapid recov ery of EEG upon reperfusion in MK -80 I-treated an imals appears fundamentally different from the ef fects previously observed with a cyclooxygenase inhibitor in which the delayed hypoperfusion phase was blocked and EEG recovered progressively over 2 h (Stevens et aI. , 1986) . We speculate that these data showing the ability of NMDA receptor activa tion to alter the delayed generation of prostanoids otherwise produced during ischemia and the similar effects of cyclooxygenase inhibition in prostanoid levels and delayed hypoperfusion indicate that an acute glutamate-evoked phase of electrical suppres sion exists initially during reflow in the presence of significant cerebral perfusion. This depressed state reflects a mechanism that shows a time-dependent reversal if there is maintained perfusion during the 2-h postreflow phase. Thus, the delayed phase of EEG suppression may reflect the progressive devel opment of the delayed ischemic state, which is in part prostanoid dependent.
In conclusion, evidence reviewed above supports the probable role of glutamate and a glutamate re ceptor in at least the early phase of the effects pro duced by ischemia: Glutamate is present, it is re leased; it evokes postsynaptic changes that mimic those observed in ischemia; and the effects of both exogenous glutamate and ischemia are diminished by the same antagonists. We stress that a develop ing literature, particularly that obtained with in vivo models concerning MK-801 and ischemia, appears to be controversial, with several laboratories find ing minimal effects (Fleischer et aI. , 1988; Perkins et aI. , 1988) , and others, as in the present studies, finding prominent actions for such agents (see in troductory section for references). We can only speculate that several issues may well contribute to these differences. Relevant variables would appear to include the degree and duration of ischemia, whole-body (e. g. , cardiac arrest) versus cerebral ischemia, forebrain versus global cerebral ischemia, and pre-versus postdrug treatment.
